DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma
β Scribed by Silvano Bosari; Arthur K. C. Lee; Steven R. Tahan; Mary Ann T. Figoni; Brian D. Wiley; Gerald I. Heatley; Mark L. Silverman
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 695 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The objective of the current study was to evaluate the effectiveness and morbidity of primary axillary radiotherapy in breast-conserving therapy for postmenopausal, clinically axillary lymph node negative patients with early stage breast carcinoma. Between 1983-1997, 105 patients with clinically neg
## Abstract ## BACKGROUND The role of axillary lymph node dissection (AxD) for patients with breast carcinoma who have clinically negative lymph nodes (cN0) and undergo breastβconserving therapy has been controversial. If patients do not undergo AxD, then it is uncertain whether specific lymph nod
Within the subgroup of lymph node-negative breast cancers, there is a need for accurate prognostic indicators to select high-risk patients. Comparative genomic hybridization (CGH) provides an opportunity to screen the whole genome for chromosomal aberrations which may be associated with poor clinica
BACKGROUND. Both axillary lymph node involvement and tumor anaplasia, as